Cytune Pharma
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Cytune Pharma - overview
Established
2007
Location
Nantes, -, France
Primary Industry
Healthcare
About
Cytune is France-based company that conceives and develops immunotherapeutic agents for fighting cancer (priority) and infectious diseases.
Current Investors
PPF Group, Remora Capital, Pays de la Loire Développement
Primary Industry
Healthcare
Sub Industries
Epidemiology, Oncology/Cancer Treatment
Website
www.cytunepharma.com
Total Amount Raised
Subscriber access only
Cytune Pharma - timeline of key events
Cytune Pharma - financials
| Fiscal Year Ended | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 |
|---|---|---|---|---|
| Revenue (USD) | 1,084,155 | - | - | - |
| % Revenue Growth (YoY) | - | - | - | - |
| EBITDA (USD) | (13,669,550) | - | - | - |
| Operating Income (USD) | (13,671,504) | - | - | - |
| Operating Margin | (1261.0%) | - | - | - |
| % EBITDA Margin | (1260.8%) | - | - | - |
| NET Income (USD) | (13,673,690) | - | - | - |
| % Net Margin | (1261.2%) | - | - | - |
Cytune Pharma - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.